
    
      Twenty-four healthy eligible Japanese male subjects and 24 healthy eligible Caucasian male
      subjects, each divided into 4 cohorts of 6 subjects, will participate in this study. No
      subject will participate in more than 1 cohort and all subjects will receive a single dose of
      P1101. Caucasian subjects will be body weight- and height-matched to Japanese subjects.

      Dosing will be initiated with the lowest dose of 100 Î¼g in both Japanese and Caucasian
      subjects.
    
  